ARTICLE | Company News
ArQule, Daiichi Sankyo deal
October 18, 2010 7:00 AM UTC
The partners extended by two years to 2012 and added a third therapeutic target with an option for a fourth target to a 2008 deal under which the partners are using ArQule's kinase inhibitor discovery...